Efficacy and tolerance of atrisin in degenerative and inflammatory joint disorders

In a randomized multi‐centre clinical trial the efficacy and tolerance of a herbal product Atrisin three capsules/day was evaluated in 65 patients (31 male, 34 female) suffering from osteoarthritis and rheumatoid arthritis, during a period of 2 months. Assessment of pain and functional disability we...

Full description

Saved in:
Bibliographic Details
Published inPhytotherapy research Vol. 19; no. 4; pp. 365 - 368
Main Authors Sohail, M.T, Chaudhry, M.I, Usman, M.K, Mian, T, Ishaq, M.N
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.04.2005
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In a randomized multi‐centre clinical trial the efficacy and tolerance of a herbal product Atrisin three capsules/day was evaluated in 65 patients (31 male, 34 female) suffering from osteoarthritis and rheumatoid arthritis, during a period of 2 months. Assessment of pain and functional disability were made on a 10 cm horizontal visual analogue scale. The severity of osteoarthritis was evaluated by Lequesne's index. Spontaneous pain showed significant improvement. Similarly there was progressive and significant reduction in the Lequesne's functional index. At the completion of the study patients taking Atrisin were using less NSAIDs. Atrisin was tolerated well by the patients and there were no adverse cardiovascular or gastric effects reported. There was feeling of general well‐being and compliance by the patients. Copyright © 2005 John Wiley & Sons, Ltd.
Bibliography:ark:/67375/WNG-TXGTJZ93-2
ArticleID:PTR1680
istex:FB2DCA9F377BEAF3C779AC19077664D31A92DCF1
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-News-3
content type line 23
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.1680